Home › Brain Tumors › Illinois › Champaign
Brain Tumors clinical trials in Champaign, IL
3 studies for Brain Tumors are looking for participants at sites in and around Champaign (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
RecruitingPhase 2
- Carle Cancer Center, Urbana · 2 mi away
- The Carle Foundation Hospital, Urbana · 2 mi away
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
RecruitingPhase 1/2
- Carle Cancer Center, Urbana · 2 mi away
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
RecruitingPhase 3
- Carle Cancer Center, Urbana · 2 mi away
About Brain Tumors
A brain tumor is a growth of abnormal cells in the brain tissue. Learn the types of tumors, symptoms, how they are diagnosed and treatment options.
More about Brain Tumors on MedlinePlus
Brain Tumors trials in other cities
- Houston, TX35 studies
- Boston, MA28 studies
- New York City, NY25 studies
- Washington, DC20 studies
- Los Angeles, CA16 studies
- Miami, FL15 studies
- Durham, NC14 studies
- St. Louis, MO12 studies
- Cleveland, OH11 studies
- Seattle, WA11 studies
- Rochester, MN11 studies
- Baltimore, MD11 studies
Other studies in Champaign
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer11 studies
- Lung Cancer9 studies
- Prostate Cancer8 studies
- Endometrial Cancer6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Melanoma6 studies
- Colorectal Cancer6 studies
- Laryngeal Cancer5 studies
- Oral Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.